Beranda › Serangan Jantung › Florida
Uji klinis Serangan Jantung di Florida
5 studi untuk Serangan Jantung mencari peserta di lokasi di Florida.
Kota di Florida
Teks studi resmi (Bahasa Inggris)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- - Boca Raton Regional - Research Physicians Network Alliance, Boca Raton
- Nova Clinical Research, LLC, Bradenton
- South Florida Nephrology Group, PA, Coral Springs
- dan 14 lainnya
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Excel Medical Clinical Trials LLC, Boca Raton
- Bay Area Cardiology Assoc, Brandon
- Jacksonville Center for Clinical Research, Jacksonville
- dan 5 lainnya
Menerima pesertaFase 3
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Excel Medical Clinical Trials, Boca Raton
- Clearwater Cardiovascular Consultants, Clearwater
- Jacksonville Center for Clinical Research, Jacksonville
- dan 14 lainnya
Menerima pesertaFase 3
Usia 50 hingga 105 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT07136012Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- University of Florida - Gainesville, Gainesville
- Tampa General Hospital, Tampa
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT04774159Focused Orticumab Research for Treating Inflammation in Coronary Arteries
- Abcentra Investigational Site, Boca Raton
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Jan 2026 · NCT06927739Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.